Trexquant Investment LP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 66 filers reported holding VIKING THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$931,507
-78.4%
84,147
-68.4%
0.02%
-79.6%
Q2 2023$4,317,031
+276.2%
266,319
+286.4%
0.11%
+253.1%
Q1 2023$1,147,601
+10.6%
68,925
-37.6%
0.03%
+10.3%
Q4 2022$1,037,892
+1106.9%
110,414
+490.0%
0.03%
+480.0%
Q4 2021$86,000
-26.5%
18,714
+0.5%
0.01%
-44.4%
Q3 2021$117,000
-8.6%
18,630
-12.5%
0.01%
-18.2%
Q2 2021$128,000
+15.3%
21,301
+8.0%
0.01%
-8.3%
Q4 2020$111,000
-68.9%
19,721
-67.9%
0.01%
-47.8%
Q3 2020$357,000
+27.0%
61,423
-4.6%
0.02%
+15.0%
Q1 2018$281,00064,4130.02%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders